Pitfalls in the interpretation of MIBG scans in cervical neuroblastoma.
Cervical neuroblastoma (CNB) is relatively rare, accounting for less than 5% of these tumors. Because it arises from the cervical sympathetic chain, complete resection will leave the child with Horner's syndrome in a high proportion of cases. Advances in technology have allowed for the development of diagnostic and imaging modalities more specific to the disease. One of these has been the advent of radiolabeled meta-iodobenzylguanidine (MIBG) to assess the primary tumor and focal metastatic involvement. This nuclide is also taken up by normal salivary-gland tissue; this may be altered, however, in the presence of sympathetic denervation. We present a case of a primary CNB associated with Horner's syndrome, which led to confusion in interpretation of the subsequent MIBG scan. We alert the reader to potential pitfalls in the use of this examination in this disease entity.
Yanchar
N L
NL
Division of Pediatric General Surgery, Children's Hospital of Eastern Ontario, Ottawa, Canada.
Chou
S
S
D019797:3-Iodobenzylguanidine; D015982:Bias; D001706:Biopsy; D006258:Head and Neck Neoplasms / Q000145:classification / Q000150:complications / Q000000981:diagnostic imaging* / Q000601:surgery; D006732:Horner Syndrome / Q000209:etiology*; D006801:Humans; D007223:Infant; D008297:Male; D009367:Neoplasm Staging / Q000379:methods; D009447:Neuroblastoma / Q000145:classification / Q000150:complications / Q000000981:diagnostic imaging* / Q000601:surgery; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine